由对万古霉素敏感性降低的金黄色葡萄球菌引起的医疗保健相关的心内膜炎。
Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
作者信息
Chi Chia-Yu, Lauderdale Tsai-Ling, Wang Shih-Min, Wu Jing-Ming, Yang Yu-Jen, Liu Ching-Chuan
机构信息
Division of Clinical Research, National Health Research Institutes, Tainan, Taiwan.
出版信息
J Clin Microbiol. 2008 Feb;46(2):810-3. doi: 10.1128/JCM.01004-07. Epub 2007 Dec 12.
Abstract
Infective endocarditis (IE) caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility (SARV) has been reported worldwide. We report the successful treatment of a pediatric patient with SARV IE and characterization of the infecting strain. The MIC of vancomycin rose from 1.5 to 2 microg/ml, and the SARV was confirmed by population analysis.
摘要
耐甲氧西林金黄色葡萄球菌伴万古霉素敏感性降低（SARV）引起的感染性心内膜炎（IE）已在全球范围内有报道。我们报告了1例SARV IE患儿的成功治疗及感染菌株的特征。万古霉素的最低抑菌浓度从1.5微克/毫升升至2微克/毫升，通过群体分析证实为SARV。
相似文献
1
Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.由对万古霉素敏感性降低的金黄色葡萄球菌引起的医疗保健相关的心内膜炎。
J Clin Microbiol. 2008 Feb;46(2):810-3. doi: 10.1128/JCM.01004-07. Epub 2007 Dec 12.
2
Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid.利奈唑胺治疗耐万古霉素中间葡萄球菌（VISA）心内膜炎。
Int J Infect Dis. 2010 Sep;14 Suppl 3:e227-9. doi: 10.1016/j.ijid.2009.07.023. Epub 2009 Dec 14.
3
In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.在兔心内膜炎模型中，新型广谱头孢菌素头孢洛林（PPI-0903）与利奈唑胺和万古霉素相比，对耐甲氧西林和万古霉素中介金黄色葡萄球菌的体内疗效。
Antimicrob Agents Chemother. 2007 Sep;51(9):3397-400. doi: 10.1128/AAC.01242-06. Epub 2007 Jun 25.
4
Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.利奈唑胺治疗耐甲氧西林金黄色葡萄球菌心内膜炎失败
Scand J Infect Dis. 2005;37(11-12):946-9. doi: 10.1080/00365540500263110.
5
Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.利奈唑胺单独使用或与万古霉素联合使用治疗耐甲氧西林金黄色葡萄球菌所致实验性心内膜炎的疗效。
Antimicrob Agents Chemother. 2003 Sep;47(9):3002-4. doi: 10.1128/AAC.47.9.3002-3004.2003.
6
Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.利奈唑胺治疗耐甲氧西林金黄色葡萄球菌所致实验性心内膜炎的疗效
Antimicrob Agents Chemother. 2001 Aug;45(8):2304-8. doi: 10.1128/AAC.45.8.2304-2308.2001.
7
Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.利奈唑胺成功治疗耐甲氧西林金黄色葡萄球菌心内膜炎。
Int J Antimicrob Agents. 2004 Jul;24(1):83-4. doi: 10.1016/j.ijantimicag.2003.12.018.
8
Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.利奈唑胺单独及与利福平联合应用于耐甲氧西林金黄色葡萄球菌心内膜炎实验模型中的疗效和药效学
J Antimicrob Chemother. 2008 Aug;62(2):381-3. doi: 10.1093/jac/dkn180. Epub 2008 Apr 28.
9
Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.由对万古霉素敏感性降低的金黄色葡萄球菌引起的感染性心内膜炎。
Clin Infect Dis. 2004 Apr 15;38(8):1188-91. doi: 10.1086/383027. Epub 2004 Apr 5.
10
Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.耐甲氧西林金黄色葡萄球菌引起的心内膜炎：利奈唑胺治疗失败
Clin Infect Dis. 2002 Oct 15;35(8):1018-20. doi: 10.1086/342698. Epub 2002 Sep 26.
引用本文的文献
1
Successful Treatment of Infective Endocarditis With Oral Antibiotics: A Case Report.口服抗生素成功治疗感染性心内膜炎：一例报告
Cureus. 2023 Aug 15;15(8):e43514. doi: 10.7759/cureus.43514. eCollection 2023 Aug.
2
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.中国14个城市异质性万古霉素中介金黄色葡萄球菌分离株的流行情况及特征
Antimicrob Agents Chemother. 2009 Sep;53(9):3642-9. doi: 10.1128/AAC.00206-09. Epub 2009 Jun 22.
本文引用的文献
1
Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.与持续性耐甲氧西林金黄色葡萄球菌菌血症相关的低水平万古霉素耐药菌株。
Antimicrob Agents Chemother. 2006 Sep;50(9):3039-47. doi: 10.1128/AAC.00422-06.
2
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.达托霉素与标准疗法治疗金黄色葡萄球菌引起的菌血症和心内膜炎的比较。
N Engl J Med. 2006 Aug 17;355(7):653-65. doi: 10.1056/NEJMoa053783.
3
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.耐甲氧西林金黄色葡萄球菌在万古霉素治疗下的适应性变化
Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S40-50. doi: 10.1086/491713.
4
In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.采用药物组合对社区获得性耐甲氧西林金黄色葡萄球菌进行体外杀灭试验。
Antimicrob Agents Chemother. 2004 Oct;48(10):4016-9. doi: 10.1128/AAC.48.10.4016-4019.2004.
5
Treatment of vancomycin-intermediate Staphylcoccus aureus endocarditis with linezolid.利奈唑胺治疗万古霉素中介金黄色葡萄球菌心内膜炎
Scand J Infect Dis. 2004;36(6-7):483-5. doi: 10.1080/00365540410015907.
6
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.万古霉素治疗耐甲氧西林金黄色葡萄球菌菌血症时的最低抑菌浓度（MIC）和杀菌活性与疗效的关系。
J Clin Microbiol. 2004 Jun;42(6):2398-402. doi: 10.1128/JCM.42.6.2398-2402.2004.
7
Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.由对万古霉素敏感性降低的金黄色葡萄球菌引起的感染性心内膜炎。
Clin Infect Dis. 2004 Apr 15;38(8):1188-91. doi: 10.1086/383027. Epub 2004 Apr 5.
8
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.对万古霉素敏感性降低的耐甲氧西林金黄色葡萄球菌引起的严重感染的治疗结果。
Clin Infect Dis. 2004 Feb 15;38(4):521-8. doi: 10.1086/381202. Epub 2004 Jan 29.
9
Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.与异质性万古霉素中介金黄色葡萄球菌所致菌血症相关的临床特征。
Clin Infect Dis. 2004 Feb 1;38(3):448-51. doi: 10.1086/381093. Epub 2004 Jan 12.
10
Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.利奈唑胺单独使用或与万古霉素联合使用治疗耐甲氧西林金黄色葡萄球菌所致实验性心内膜炎的疗效。
Antimicrob Agents Chemother. 2003 Sep;47(9):3002-4. doi: 10.1128/AAC.47.9.3002-3004.2003.
Zotero 插件